Glenn P. Sblendorio
2013 - Medicines
In 2013, Glenn P. Sblendorio earned a total compensation of $2.7M as Former President and Chief Financial Officer at Medicines, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $484,756 |
|---|---|
| Option Awards | $501,770 |
| Salary | $569,296 |
| Stock Awards | $1,175,994 |
| Other | $3,214 |
| Total | $2,735,030 |
Sblendorio received $1.2M in stock awards, accounting for 43% of the total pay in 2013.
Sblendorio also received $484.8K in non-equity incentive plan, $501.8K in option awards, $569.3K in salary and $3.2K in other compensation.
Rankings
In 2013, Glenn P. Sblendorio's compensation ranked 2,812th out of 12,286 executives tracked by ExecPay. In other words, Sblendorio earned more than 77.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,812 out of 12,286 | 77th |
Division Manufacturing | 938 out of 4,614 | 80th |
Major group Chemicals And Allied Products | 245 out of 1,466 | 83rd |
Industry group Drugs | 164 out of 1,160 | 86th |
Industry Pharmaceutical Preparations | 136 out of 890 | 85th |
Source: SEC filing on April 25, 2016.
Sblendorio's colleagues
We found three more compensation records of executives who worked with Glenn P. Sblendorio at Medicines in 2013.